Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen

NCT02623556 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1090

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: ESAT6-CFP10 (10ug/ml) in left arm and TB-PPD in right arm
BIOLOGICAL: ESAT6-CFP10 (10ug/ml) in right arm and TB-PPD in left arm

Sponsor

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]